STTR

SBA Awards Over $5.4 Million in Grants to Strengthen Research Funding Opportunities Across the U.S.

Retrieved on: 
Friday, September 30, 2022

FAST provides small businesses and startups, particularly those in underserved communities, with specialized training, mentoring, and technical assistance for research and development.

Key Points: 
  • FAST provides small businesses and startups, particularly those in underserved communities, with specialized training, mentoring, and technical assistance for research and development.
  • This years expansion of the FAST program created 12 additional awards and expands the programs footprint to 43 states and one U.S. territory.
  • With $4 million in funding in fiscal year 2021, FAST helped small businesses to win over $88 million in SBIR and STTR awards, a 22:1 return for every taxpayer dollar spent.
  • The FAST program provides awards for a base period of 12 months, plus four optional continuation periods of 12 months each.

New York State Small Business Owner Molly Bakewell Chamberlin Re-Appointed to National Small Business Association Leadership and Technology Councils

Retrieved on: 
Friday, September 23, 2022

Based in Washington, D.C., NSBA is the nation's oldest non-partisan small business advocacy organization.

Key Points: 
  • Based in Washington, D.C., NSBA is the nation's oldest non-partisan small business advocacy organization.
  • The NSBA Leadership Council provides valuable networking opportunities while ensuring that small business owners have a vital seat at the table, as Congress and regulators take up key small business proposals.
  • Notes NSBA president and CEO, Todd McCracken, "Molly Bakewell Chamberlin has been a tremendous asset to the NSBA and our various Councils.
  • To learn more about Molly Bakewell Chamberlin, visit her LinkedIn profile here: https://www.linkedin.com/in/mollychamberlin/ To learn more about Embassy Global, visit www.embassyglobalpr.com .

Tangram Flex awarded SpaceWERX Orbital Prime Contract

Retrieved on: 
Thursday, September 22, 2022

Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation.

Key Points: 
  • Orbital Prime was created to accelerate the commercial ISAM market toward a use case of Active Debris Remediation.
  • Tangram Flex is a product-driven software company that provides custom service and expertise in system modernization, integration, assurance, and autonomy.
  • SpaceWERX Orbital Prime leverages a diverse industry partnership engagement strategy to identify nascent space technology sectors that, if "primed", could advance U.S. national security and economic prosperity.
  • The first Space Prime effort, Orbital Prime will invigorate the In-space Servicing, Assembly, and Manufacturing (ISAM) market using Active Debris Remediation (ADR) as a use case for the foundational technologies.

South Rampart Pharma Receives Year 3 of NIH Fast-Track STTR Commercialization Grant

Retrieved on: 
Thursday, September 22, 2022

The NIH grant is entitled 'Novel non-narcotic analgesic for acute and chronic pain.'

Key Points: 
  • The NIH grant is entitled 'Novel non-narcotic analgesic for acute and chronic pain.'
  • Importantly, SRP-001 mirrors acetaminophen's clinically validated mechanism of action while simultaneously muting the biological activity that causes liver toxicity.
  • South Rampart Pharma is currently conducting an ongoing Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of SRP-001.
  • South Rampart Pharma's lead program, SRP-001, is a novel acetaminophen analog with a unique mechanism of action for its lack of liver toxicity present in acetaminophen.

VIC Foundry Awarded an NIH Grant for Development of Instrument for Ultrafast Detection of Protein Biomarkers

Retrieved on: 
Tuesday, September 20, 2022

FAYETTEVILLE, Ark. , Sept. 20, 2022  /PRNewswire-PRWeb/ -- VIC Foundry, in collaboration with the University of Buffalo, has been awarded a $259,000 grant from the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program. STTR grants support research and development to de-risk new technologies that have significant commercial potential.

Key Points: 
  • The microreactor can be directly coupled to mass spectrometry for ultrafast (near real-time), unambiguous detection of protein biomarkers.
  • In diagnosis, risk stratification, and management of many life-threatening diseases/conditions such as myocardial infarction, every minute counts and unambiguous detection of relevant protein biomarkers is crucial.
  • VIC Foundry is one element of the VIC innovation ecosystem that includes VIC Tech, VIC Investor Network, and various associated programs such as the VIC Fellows.
  • VIC Foundry develops technologies that have substantial potential impact and commercial promise but need additional development before private equity funding.

Space Force Selects GURU, Georgia Tech, UCF to Accelerate On-Orbit Operations

Retrieved on: 
Tuesday, September 13, 2022

Example applications include repair and refueling of existing satellites, removing and recycling orbital debris, and manufacturing products in space.

Key Points: 
  • Example applications include repair and refueling of existing satellites, removing and recycling orbital debris, and manufacturing products in space.
  • With Orbital Prime, the Space Force is "finally planting a flag" and putting in real money.
  • Headquartered at the Los Angeles AFWERX hub, SpaceWERX inspires and empowers collaboration with innovators to accelerate capabilities and shape our future in space.
  • MSBAI is a privately held small business located in Los Angeles, CA, developing GURU, so you can set up simulations in minutes.

National Institute of Health (NIH) awards InfeXtious Therapeutic a Small Business Technology Transfer (STTR) grant for the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance

Retrieved on: 
Thursday, September 8, 2022

IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ -- InfeXtious Therapeutic announces a Small Business Technology Transfer (STTR) grant award from the National Institute of Health (NIH). In collaboration with Dr. Rakesh Tiwari of Chapman University, the grant will support the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance.

Key Points: 
  • IRVINE, Calif., Sept. 8, 2022 /PRNewswire/ -- InfeXtious Therapeutic announces a Small Business Technology Transfer (STTR) grant award from the National Institute of Health (NIH).
  • In collaboration with Dr. Rakesh Tiwari of Chapman University, the grant will support the development of broad-spectrum cyclic amphiphilic peptides to combat antimicrobial resistance.
  • The overuse of antibiotic drugs in agriculture, aquaculture, animal feed, and medicinehas led to the development of antibiotic-resistant bacteria.
  • InfeXtious Therapeutic is a small biotechnology company with a novel cyclic peptides platform to combat antimicrobial resistance.

Aerobotix Marks 40th Restoration of Air Inlet Ducts on F-22 Raptor Aircraft

Retrieved on: 
Wednesday, August 31, 2022

Aerobotix , an AS9100-certified FANUC robotics integrator, today marked having supported the 40th restoration of air inlet ducts on F-22 Raptor aircraft, as part of a maintenance contract with the U.S. Air Force.

Key Points: 
  • Aerobotix , an AS9100-certified FANUC robotics integrator, today marked having supported the 40th restoration of air inlet ducts on F-22 Raptor aircraft, as part of a maintenance contract with the U.S. Air Force.
  • Thats a labor saving of around 80%, so it really solves the challenge of getting these aircraft back into service quicker.
  • We estimate that since 2016, weve helped the Air Force save $8.8 million $220,000 per aircraft in maintenance costs.
  • On jet aircraft, inlets ensure smooth airflow into engines despite turbulent air coming at the ducts from multiple directions.

OmniSync Incorporated Awarded a Phase II SBIR Contract by The US Air Force to Automate Contracting Processes

Retrieved on: 
Tuesday, August 30, 2022

The investigation is being conducted with collaborative feedback from the 39th and the 92nd Contracting Squadrons in the Air Force.

Key Points: 
  • The investigation is being conducted with collaborative feedback from the 39th and the 92nd Contracting Squadrons in the Air Force.
  • "We pride ourselves on developing cutting-edge innovations and are thrilled to continue our work to support the US Air Force.
  • The Air Force Research Laboratory (AFRL) is the primary scientific research and development center for the Department of the Air Force.
  • AFWERX, a program office at the Air Force Research Laboratory (AFRL), connects innovators across government, industry and academia.

South Rampart Pharma Announces Late-Breaking Presentation at IASP 2022 World Congress on Pain

Retrieved on: 
Thursday, August 25, 2022

NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced that the Company will present a late-breaking abstract at the International Association for the Study of Pain (IASP) 2022World Congress on Pain, which will take place on September 20-23, 2022, in Toronto, Canada.

Key Points: 
  • NEW ORLEANS, Aug. 25, 2022 /PRNewswire/ -- South Rampart Pharma ("South Rampart" or the "Company"), a clinical-stage life science company advancing innovative medications for the treatment of pain and fever, today announced that the Company will present a late-breaking abstract at the International Association for the Study of Pain (IASP) 2022World Congress on Pain, which will take place on September 20-23, 2022, in Toronto, Canada.
  • South Rampart's CEO and Co-founder, Hernan Bazan, MD, FACS, will deliver the presentation.
  • The World Congress on Pain is the largest global gathering of pain professionals.
  • South Rampart Pharma is a clinical-stage life science company dedicated to advancing the safe treatment of pain by developing new small molecule solutions that can overcome many risks associated with current pain medicines.